| Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers (NCT02161432) | Boehringer Ingelheim | 2014-06-01 |
| Phase 1 Safety and PK Study of OLT1177 Capsules (NCT02134964) | Olatec Therapeutics, Inc. | 2014-06-01 |
| CKD-330 Drug-Drug Interaction Study (Candesartan) (NCT02064621) | Chong Kun Dang Pharmaceutical | 2014-06-01 |
| Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin (NCT02206087) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2014-06-01 |
| A Study to Evaluate the Effect of Intranasal Esketamine on Cognitive Functioning in Healthy Subjects (NCT02094378) | Janssen Research & Development, LLC | 2014-06-01 |
| Partial Liver Segment 2/3 Transplantation Study (NCT02215889) | Oslo University Hospital | 2014-06-01 |
| Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects (NCT02172313) | Novo Nordisk A/S | 2014-06-01 |
| Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol (NCT02170038) | Bayer | 2014-06-01 |
| Treatment of Primary Liver Tumors With Electrochemotherapy (ECT) (NCT02291133) | Masa Bosnjak | 2014-06-01 |
| Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD (NCT02167048) | University of British Columbia | 2014-06-01 |
| Multiple Ascending Dose Study of GLPG0634 in Japanese and Caucasian Healthy Subjects (NCT02162355) | Lakefront Biotherapeutics NV | 2014-06-01 |
| Drug-Drug Interaction Study in Healthy Adult Volunteers (NCT02275988) | Kowa Research Institute, Inc. | 2014-06-01 |
| A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer (NCT02176746) | Fuda Cancer Hospital, Guangzhou | 2014-06-01 |
| Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I (NCT02173873) | Rafic Hariri University Hospital | 2014-06-01 |
| Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia (NCT02170311) | Zeria Pharmaceutical | 2014-06-01 |
| Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma (NCT02191878) | Arbutus Biopharma Corporation | 2014-06-01 |
| The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure (NCT02129179) | Papworth Hospital NHS Foundation Trust | 2014-06-01 |
| Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients (NCT02346175) | Jiangsu HengRui Medicine Co., Ltd. | 2014-06-01 |
| A Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety of AC-170 0.24% (NCT02173249) | Aciex Therapeutics, Inc. | 2014-06-01 |
| Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above (NCT02126761) | Seqirus | 2014-06-01 |
| The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding (NCT02326922) | Ain Shams Maternity Hospital | 2014-06-01 |
| Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects (NCT02223871) | Idorsia Pharmaceuticals Ltd. | 2014-06-01 |
| Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®) (NCT02179931) | H. Lundbeck A/S | 2014-06-01 |
| Relative Bioavailability Study (NCT02159313) | Bayer | 2014-06-01 |
| A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants (NCT02156492) | Eli Lilly and Company | 2014-06-01 |
| Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants (NCT02161731) | Eli Lilly and Company | 2014-06-01 |
| Phase I Study of Oral DFP-11207 in Solid Tumors (NCT02171221) | Delta-Fly Pharma, Inc. | 2014-06-01 |
| VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer (NCT02294565) | Vestan, Inc. | 2014-06-01 |
| A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477 (NCT02164266) | Hoffmann-La Roche | 2014-06-01 |
| Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder. (NCT02163915) | Takeda | 2014-06-01 |
| Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD) (NCT02185820) | European Myeloma Network B.V. | 2014-06-01 |
| Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus (NCT02121483) | Boehringer Ingelheim | 2014-06-01 |
| A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects (NCT02161588) | Novo Nordisk A/S | 2014-06-01 |
| 68Ga-OPS202 Study for Diagnostic Imaging of GEP NET (NCT02162446) | Ipsen | 2014-06-01 |
| Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells With Platelet Rich Plasma (NCT02365142) | Clinica Universidad de Navarra, Universidad de Navarra | 2014-06-01 |
| A Bioavailability Study of Methotrexate 25 mg Administered by Needle Injection and a Pre Filled Needle-free Device in Healthy Volunteers. (NCT03103334) | Crossject | 2014-06-01 |
| The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers. (NCT02174250) | Kyowa Kirin Co., Ltd. | 2014-06-01 |
| Evaluation of Topical Citrullus Colocynthis Fruit Oil Efficacy in Treatment of Painful Peripheral Diabetic Neuropathy (NCT02155361) | Shiraz University of Medical Sciences | 2014-06-01 |
| Subcutaneous Wound Infiltration of Ketamine or Bupivacaine Pain Perception After Cesarean Section (NCT02515422) | Huseyin Aksoy | 2014-06-01 |
| Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects (NCT02318836) | USWM, LLC (dba US WorldMeds) | 2014-06-01 |
| Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis (NCT02165176) | Johns Hopkins University | 2014-06-01 |
| Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD) (NCT02176317) | Duke University | 2014-06-01 |
| Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole (NCT02190708) | Vivoryon Therapeutics N.V. | 2014-06-01 |
| Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of ENV8058 (TAK-058) in Healthy Participants (NCT02153099) | Takeda | 2014-06-01 |
| Using Computer Tasks to Predict Response to Antidepressants (NCT02800577) | P1vital Products Limited | 2014-06-01 |
| OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients (NCT02880475) | Mundipharma (China) Pharmaceutical Co. Ltd | 2014-06-01 |
| Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) (NCT02117336) | Piramal Enterprises Limited | 2014-06-01 |
| A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device (NCT02146781) | Immunomic Therapeutics, Inc. | 2014-06-01 |
| Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer (NCT02151721) | Kanazawa University | 2014-06-01 |
| A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis (NCT02144285) | Eli Lilly and Company | 2014-06-01 |
| Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma (NCT02148913) | Corewell Health West | 2014-06-01 |
| Bioequivalence Study of CJ-30059 (NCT02173912) | HK inno.N Corporation | 2014-06-01 |
| CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer (NCT02074878) | Mothaffar Rimawi | 2014-06-01 |
| Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI (NCT02439398) | Coretherapix | 2014-06-01 |
| Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants (NCT02159352) | Bristol-Myers Squibb | 2014-06-01 |
| A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649 (NCT02151617) | Pfizer | 2014-06-01 |
| Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome (NCT02153983) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2014-05-31 |
| Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection (NCT02128217) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-05-30 |
| Dobutamine in the Treatment of Haemodynamic Insufficiency in the Immediate Postnatal Period (NCT03311178) | Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz | 2014-05-30 |
| Food Effect and CYP1A2 Induction Study in Healthy Subjects (NCT02168205) | Celgene | 2014-05-30 |
| Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1 (NCT02122861) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-05-30 |
| A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022) (NCT02130466) | Merck Sharp & Dohme LLC | 2014-05-29 |
| Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02097225) | National Cancer Institute (NCI) | 2014-05-29 |
| Challenge Model for Assessment of Human TB Immunity (NCT01868464) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-05-28 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee (NCT02126826) | Boehringer Ingelheim | 2014-05-28 |
| TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD) (NCT02117427) | Aevi Genomic Medicine, LLC, a Cerecor company | 2014-05-27 |
| Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma (NCT01995669) | M.D. Anderson Cancer Center | 2014-05-27 |
| Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults (NCT02151110) | MedImmune LLC | 2014-05-27 |
| Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas (NCT02055924) | The Lymphoma Academic Research Organisation | 2014-05-26 |
| Relative Bioavailability Study of CC-292 (NCT02433457) | Celgene | 2014-05-26 |
| A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis (NCT02196558) | Eisai Co., Ltd. | 2014-05-26 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes (NCT02148861) | Novo Nordisk A/S | 2014-05-26 |
| A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011) (NCT01558674) | Merck Sharp & Dohme LLC | 2014-05-23 |
| Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma (NCT02141347) | AstraZeneca | 2014-05-22 |
| Dose-escalation Study of Lupartumab Amadotin (BAY1129980) (NCT02134197) | Bayer | 2014-05-22 |
| Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer (NCT02138383) | H. Lee Moffitt Cancer Center and Research Institute | 2014-05-22 |
| Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer (NCT02172846) | Washington University School of Medicine | 2014-05-22 |
| MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma (NCT02057640) | Jason Valent | 2014-05-22 |
| BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx (NCT02038010) | Northwestern University | 2014-05-21 |
| A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes (NCT02147431) | Novo Nordisk A/S | 2014-05-21 |
| A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects (NCT02146079) | Novo Nordisk A/S | 2014-05-21 |
| TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors (NCT02142803) | National Cancer Institute (NCI) | 2014-05-20 |
| Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery (NCT02160015) | National Cancer Institute (NCI) | 2014-05-20 |
| Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome (NCT02117219) | MedImmune LLC | 2014-05-20 |
| Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma (NCT02062749) | M.D. Anderson Cancer Center | 2014-05-19 |
| Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer (NCT02088684) | Novartis Pharmaceuticals | 2014-05-19 |
| Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer (NCT01970722) | City of Hope Medical Center | 2014-05-19 |
| Japanese BAY1000394 Monotherapy Phase I Study (NCT02047890) | Bayer | 2014-05-19 |
| A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies (NCT02118337) | MedImmune LLC | 2014-05-19 |
| Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01787474) | M.D. Anderson Cancer Center | 2014-05-19 |
| c-Met Second-Line Hepatocellular Carcinoma (NCT02115373) | Merck KGaA, Darmstadt, Germany | 2014-05-18 |
| Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies (NCT02116777) | National Cancer Institute (NCI) | 2014-05-16 |
| BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer (NCT02123823) | Boehringer Ingelheim | 2014-05-15 |
| Evaluation of [18F]Fluoroethyl Triazole Labelled [Tyr3]-Octreotate Analogues for the Imaging of Neuroendocrine Tumours. (NCT06456723) | Imperial College London | 2014-05-14 |
| Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer (NCT01737502) | Mayo Clinic | 2014-05-14 |
| A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4 (NCT02091999) | Astellas Pharma Global Development, Inc. | 2014-05-14 |
| A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants (NCT02093923) | Shire | 2014-05-14 |
| Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors (NCT02077933) | Novartis Pharmaceuticals | 2014-05-14 |
| Drug-drug Interaction (DDI) Rifabutin (NCT02138084) | ViiV Healthcare | 2014-05-14 |
| Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors (NCT02071537) | University of Cincinnati | 2014-05-13 |